Carlyle to take minority stake in Piramal Pharma

The Carlyle Group has agreed to acquire a 20 percent stake in Piramal Pharma for $490 million.

29 June 2020•6 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles